Full-Thickness Resection Device for Complex Colorectal Lesions in High-Risk Patients as a Last-Resort Endoscopic Treatment: Initial Clinical Experience and Review of the Current Literature
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Edris WEDI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Beatrice ORLANDINI
			        		
			        		;
		        		
		        		
		        		
			        		Mark GROMSKI
			        		
			        		;
		        		
		        		
		        		
			        		Carlo Felix Maria JUNG
			        		
			        		;
		        		
		        		
		        		
			        		Irina TCHOUMAK
			        		
			        		;
		        		
		        		
		        		
			        		Stephanie BOUCHER
			        		
			        		;
		        		
		        		
		        		
			        		Volker ELLENRIEDER
			        		
			        		;
		        		
		        		
		        		
			        		Jürgen HOCHBERGER
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Case Report
 - Keywords: Colonoscopy; Colorectal neoplasms; Full-thickness resection device; Over-the-scope-clip
 - MeSH: Adenocarcinoma; Adenoma; Anastomosis, Surgical; Colon; Colonoscopy; Colorectal Neoplasms; Humans; Immunosuppression; Kidney Transplantation; Lifting; Proctocolitis
 - From:Clinical Endoscopy 2018;51(1):103-108
 - CountryRepublic of Korea
 - Language:English
 - Abstract: The full-thickness resection device (FTRD) is a novel endoscopic device approved for the resection of colorectal lesions. This case-series describes the device and its use in high-risk patients with colorectal lesions and provides an overview of the potential indications in recently published data. Between December 2014 and September 2015, 3 patients underwent endoscopic full thickness resection using the FTRD for colorectal lesions: 1 case for a T1 adenocarcinoma in the region of a surgical anastomosis after recto-sigmoidectomy, 1 case for a non-lifting colonic adenoma with low-grade dysplasia in an 89-year old patient and 1 for a recurrent adenoma with high-grade dysplasia in a young patient with ulcerative rectocolitis who was under immunosuppression after renal transplantation. Both technical and clinical success rates were achieved in all cases. The size of removed lesions ranged from 9 to 30 mm. Overall, the most frequent indication in the literature has been for lifting or non-lifting adenoma, submucosal tumors, neuroendocrin tumors, incomplete endoscopic resection (R1) or T1 carcinoma. Colorectal FTRD is a feasible technique for the treatment of colorectal lesions and represents a minimally invasive alternative for either surgical or conventional endoscopic resection strategies.
 
            